| Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction JG Abelin, DB Keskin, S Sarkizova, CR Hartigan, W Zhang, J Sidney, ... Immunity 46 (2), 315-326, 2017 | 578 | 2017 |
| A large peptidome dataset improves HLA class I epitope prediction across most of the human population S Sarkizova, S Klaeger, PM Le, LW Li, G Oliveira, H Keshishian, ... Nature biotechnology 38 (2), 199-209, 2020 | 383 | 2020 |
| The NORAD lncRNA assembles a topoisomerase complex critical for genome stability M Munschauer, CT Nguyen, K Sirokman, CR Hartigan, L Hogstrom, ... Nature 561 (7721), 132-136, 2018 | 335 | 2018 |
| Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9 RK Schneider, M Schenone, MV Ferreira, R Kramann, CE Joyce, ... Nature medicine 22 (3), 288-297, 2016 | 234 | 2016 |
| Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer T Ouspenskaia, T Law, KR Clauser, S Klaeger, S Sarkizova, F Aguet, B Li, ... Nature biotechnology 40 (2), 209-217, 2022 | 183 | 2022 |
| Type 2 diabetes variants disrupt function of SLC16A11 through two distinct mechanisms V Rusu, E Hoch, JM Mercader, DE Tenen, M Gymrek, CR Hartigan, ... Cell 170 (1), 199-212. e20, 2017 | 153 | 2017 |
| The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer M Gandhi, M Groß, JM Holler, SAA Coggins, N Patil, JH Leupold, ... Nature communications 11 (1), 3214, 2020 | 99 | 2020 |
| Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics L De Waal, TA Lewis, MG Rees, A Tsherniak, X Wu, PS Choi, L Gechijian, ... Nature chemical biology 12 (2), 102-108, 2016 | 93 | 2016 |
| Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation A Basak, M Munschauer, CA Lareau, KE Montbleau, JC Ulirsch, ... Nature genetics 52 (2), 138-145, 2020 | 89 | 2020 |
| Cohesin mutations alter DNA damage repair and chromatin structure and create therapeutic vulnerabilities in MDS/AML Z Tothova, AL Valton, RA Gorelov, M Vallurupalli, JM Krill-Burger, ... JCI insight 6 (3), 2021 | 50 | 2021 |
| CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1 R Belizaire, SHJ Koochaki, ND Udeshi, A Vedder, L Sun, T Svinkina, ... Blood, The Journal of the American Society of Hematology 137 (16), 2209-2220, 2021 | 32 | 2021 |
| Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor B Roux, C Vaganay, JD Vargas, G Alexe, C Benaksas, B Pardieu, ... Science translational medicine 13 (587), eabg1168, 2021 | 31 | 2021 |
| Domain-specific quantification of prion protein in cerebrospinal fluid by targeted mass spectrometry EV Minikel, E Kuhn, AR Cocco, SM Vallabh, CR Hartigan, ... Molecular & Cellular Proteomics 18 (12), 2388-2400, 2019 | 22 | 2019 |
| Memory T‐cell exhaustion and tolerance in transplantation CR Hartigan, H Sun, ML Ford Immunological Reviews 292 (1), 225-242, 2019 | 22 | 2019 |
| Publisher Correction: The NORAD lncRNA assembles a topoisomerase complex critical for genome stability M Munschauer, CT Nguyen, K Sirokman, CR Hartigan, L Hogstrom, ... Nature 563 (7733), E32, 2018 | 20 | 2018 |
| TIGIT regulates apoptosis of risky memory T cell subsets implicated in belatacept-resistant rejection H Sun, CR Hartigan, C Chen, Y Sun, M Tariq, JM Robertson, ... American Journal of Transplantation 21 (10), 3256-3267, 2021 | 17 | 2021 |
| Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography–Tandem Mass Spectrometry RWA Peake, CR Hartigan, CL Esposito, MD Kellogg, J Gabler, S Wang, ... Therapeutic Drug Monitoring 37 (2), 161-171, 2015 | 16 | 2015 |
| TIGIT agonism alleviates costimulation blockade-resistant rejection in a regulatory T cell–dependent manner CR Hartigan, KP Tong, D Liu, SJ Laurie, ML Ford American Journal of Transplantation 23 (2), 180-189, 2023 | 10 | 2023 |
| Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes C Loveday, A Garrett, P Law, S Hanks, E Poyastro-Pearson, JW Adlard, ... Annals of oncology 33 (12), 1318-1327, 2022 | 9 | 2022 |
| Noncanonical translation via deadenylated 3′ UTRs maintains primordial germ cells YN Jin, PJ Schlueter, N Jurisch-Yaksi, PY Lam, S Jin, WY Hwang, ... Nature chemical biology 14 (9), 844-852, 2018 | 9 | 2018 |
